MMP9 and glioblastoma: miR-223 is another well-recognized oncogenic miRNA, which, in glioblastoma, promotes growth and invasion of tumor cells by targeting the tumor suppressor PAX6, exerting its function by inhibiting the expression of metalloproteases MMP2 and MMP9 [91].